Evogene (EVGN) Tops Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $640 thousand versus the consensus estimate of $590 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c